HomeASBP • NASDAQ
add
Aspire Biopharma Holdings Inc
Previous close
$0.10
Day range
$0.10 - $0.11
Year range
$0.088 - $15.80
Market cap
11.18M USD
Avg Volume
44.60M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.94K | — |
Operating expense | 1.15M | 432.57% |
Net income | -1.85M | -755.64% |
Net profit margin | -95.34K | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.95M | 11,678.44% |
Total assets | 2.40M | 1,205.76% |
Total liabilities | 13.87M | 1,307.26% |
Total equity | -11.47M | — |
Shares outstanding | 107.48M | — |
Price to book | -0.44 | — |
Return on assets | -168.83% | — |
Return on capital | 143.69% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.85M | -755.64% |
Cash from operations | -1.10M | -122.75% |
Cash from investing | — | — |
Cash from financing | 2.85M | 477.86% |
Net change in cash | 1.74M | 56,973.59% |
Free cash flow | 3.86M | 942.26% |
About
Founded
2021
Website
